Research Projects
Exploring antimicrobial resistance plasmid diversity at a single hospital network in a 7-year period
Plasmid transmission between bacteria of the same or different species is an important driver of genetic diversity, bacterial adaptation and...
Supervisor: Dr Margaret Lam
Fatigue and tiredness after stroke is a commonly reported symptom, although early after stroke people often struggle to understand the term when...
Supervisor: Professor Natasha Lannin
Background: Advanced glycation endproducts (AGEs), formed via the processing of foods, are a major constituent of our modern convenience diet....
Supervisor: Professor Melinda Coughlan
The brain's waste clearance system, the glymphatic system, is essential for maintaining a healthy neuronal environment and homeostasis....
Supervisor: Dr Ben Sinclair
Glioblastoma is a rare brain tumour, with an annual incidence of 6.8 per 100,000 people in Australia, with a 5-year survival rate of less than 5%....
Supervisor: Dr Neha Kaul
Around 70 million people worldwide have epilepsy and more than 30% of patients are drug-resistant. Drug resistance is currently an unmet need due to...
Supervisor: Dr. Shahid Javaid
The cEEG and Stem Cell Laboratory in the Department of Neuroscience are investigating new treatments for a class of patients that do not respond to...
Supervisor: A/Prof Pablo Casillas-Espinosa MD, PhD
This research program aims to evaluate the acceptability, feasibility and fidelity of a co-designed FRAIL-Scale to inform preventive strategies for...
Supervisor: Dr Ching Shan (Angela) Wan
Gastric cancer (GC) is the fourth most common cancer globally. It has defined premalignant stages and progresses through Intestinal Metaplasia (IM)...
Supervisor: Professor Alex Boussioutas
Generating mouse models of clonal hematopoiesis to study the potential of apsirin to prevent cancers
Clonal haematopoiesis of indeterminate potential (CHIP), defined as the presence of blood cancer-associated mutations with a variant allele frequency...
Supervisor: Professor David Curtis
Acquired epilepsy is the most common form of drug resistant acquired epilepsy in adults, where seizures continue to occur despite antiepileptic drug...
Supervisor: A/Prof Pablo Casillas-Espinosa MD, PhD
The global antimicrobial resistance crisis is predicted to result in 10 million yearly deaths by 2050 and has re-galvanised interest in the use of...
Supervisor: Assoc/Prof Kelly Wyres
Klebsiella pneumoniae is a major cause of antibiotic resistant hospital-associated infections that can be extremely difficult to treat. The World...
Supervisor: Assoc/Prof Kelly Wyres
Antimicrobial resistance (AMR) is a key global issue, with resistance to important antibiotics increasing yearly, resulting in 1.14 million deaths in...
Supervisor: Dr Margaret Lam
Type one diabetes (T1D) has reached epidemic proportions and people living with the disease are dependent on insulin therapy to help keep their blood...
Supervisor: Prof Christoph Hagemeyer
Understanding how the immune system recognizes pathogens guides us in the development of immune therapeutics for diseases such as cancer. So far,...
Supervisor: Dr Jessica Da Gama Duarte
The level of mortality and disease among pregnant women and young children in Papua New Guinea is very high. Low birthweight and poor growth during...
Supervisor: Professor James Beeson
Epilepsy is a severe neurological disorder characterized by recurrent seizures that affect 1% of the population worldwide. Traumatic brain injury (...
Supervisor: A/Prof Pablo Casillas-Espinosa MD, PhD
Plasma cells (PC) are the only cell type secreting antibodies, which are important for protective immunity to fight against pathogens. However,...
Supervisor: Dr Zhoujie (Zoe) Ding
The acquisition of resistance to therapies by cancer cells, sadly, is often inevitable. To effectively treat cancer, we need to understand how...
Supervisor: Dr Omer Gilan